Current approaches to radiation therapy for malignant gliomas

Frontiers of Radiation Therapy and Oncology

Volumn 33, Issue , 1999, Pages 139-149

  Brada, Michael ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; GLIOMA; HUMAN; NEUTRON CAPTURE THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; STEREOTAXIC SURGERY;

BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; DOSE FRACTIONATION; GLIOMA; HUMANS; RADIOTHERAPY DOSAGE; STEREOTAXIC TECHNIQUES;

EID: 0032647486     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061230     Document Type: Article

References (42)

1. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, et al:Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A Prospective Multicenter Trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-652.
2. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, et al:Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978;49:333-343.
3. Sandberg WM, Malmström P, Strömblad LG, Anderson H, Borgström S, Brun A, et al:A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 1991;68:22-29.
4. Walker MD, Strike TA, Sheline GE:An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725.
5. Bleehen NM, Stenning SP, on behalf of the Medical Research Council Brain Tumour Working Party:A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-774.
6. Chang CH, Horton J, Schoenfeld D, Salazar O, Perez Tamayo R, Kramer S, et al:Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983;52:997-1007.
7. Burger P, Heinz E, Shibata T, Kleihues P:Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:698.
8. Halperin EC, Bentel G, Heinz ER, Burger PC:Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post-mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989;17:1347-1350.
9. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG:Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409.
10. Shapiro WR, Green SB, Burger PC, Mahaley MSJ, Selker RG, VanGilder JC, et al:Randomised trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 1989;71:1-9.
11. Stenning S, Freedman LS, Bleehen NM, Medical Research Council Brain Tumour Working Party:Prognostic factors for high grade glioma: Development of a prognostic index. J Neurooncol 1990;9:47-55.
12. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach J, et al:Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group Malignant Glioma Trials. J Natl Cancer Inst 1993;85:704-710.
13. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al:Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998;40:51-55.
14. Thomas R, James N, Guerrero D, Ashley S, Gregor A, Brada M:Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 1994;33:113-116.
15. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG:A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835-839.
16. Kleinberg L, Slick T, Enger C, Grossman S, Brem H, Wharam MD Jr:Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys 1997;38:31-36.
17. Fallai C, Olmi P:Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases). Radiother Oncol 1997;43:235-246.
18. Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, et al:Hyperfractionated radiation therapy and bis-chlorethyl-nitrosourea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy BID fractions: Report of the Radiation Therapy Oncology Group Protocol 83 02. Int J Radiat Oncol Biol Phys 1993;25:193-207.
19. Brada M, Sharpe G, Rajan B, Britten J,Wilkins P, Guererro D, et al:Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. Int J Radiol Oncol Biol Phys 1999;43:287-292.
20. Brada M, Thomas G, Elyan S, James N, Hines F, Ashley S, et al:Improving the acceptability of high dose radiotherapy by reducing the duration of treatment: Accelerated radiotherapy in high grade glioma. Br J Cancer 1995;71:1330-1334.
21. Bleehen NM:Studies of high grade cerebral gliomas. Int J Radiat Oncol Biol Phys 1990;18:811-813.
22. Chang CH:Hyperbaric oxygen and radiation therapy in the management of glioblastoma; in Modern Concepts in Brain Tumour Therapy: Laboratory and Clinical Investigations. Natl Cancer Inst Monogr No 46. Washington, US Government Printing Office, 1977, p 163.
23. Catterall M, Bloom HJG, Ash DV,Walsh L, Richardson A, Uttley D, et al:Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study. Int J Radiat Oncol Biol Phys 1980;6:261-266.
24. Duncan W, McLelland J, Jack WJL:Report of a randomised pilot study of the treatment of patients with supratentorial gliomas using neutron irradiation. Br J Radiol 1986;59:373.
25. Chang EL, Loeffler JS, Riese NE, Wen PY, Alexander ER, Black PM, et al:Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Int J Radiat Oncol Biol Phys 1998;40:65-70.
26. Liang B, Weil M:Locoregional approaches to therapy with gliomas as the paradigm. Curr Opin Oncol 1998;10:201-206.
27. McDermott MW, Sneed PK, Gutin PH:Interstitial brachytherapy for malignant brain tumors. Semin Surg Oncol 1998;14:79-87.
28. Florell R, MacDonald D, Irish W, Bernstein M, Leibel S, Gutin P, et al:Selection bias, survival, and brachytherapy for glioma. J Neurosurg 1992;76:179-183.
29. Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, et al:Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998;41:1005-1011.
30. Loeffler JS, Alexander E,Kooy HM,Wen PY:Results of radiosurgery used in the initial management of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 1991;21(suppl 1):171.
31. Mehta MP, Masciopinto J,Rozental J, Levin A, Chappell R, Bastin K, et al:Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 1994;30:541-549.
32. Curran WJ, Scott CB,Weinstein AS, Martin LA, Nelson JS, Phillips TL, et al:Survival comparison of radiosurgery eligible and ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83 02. J Clin Oncol 1993;11:857-862.
33. Colapinto EV, Zalutsky MR, Archer GE:RIT of intercranial human glioma xenografts with 131Ilabelled F(ab)2 fragments of Mab Mel 14. Cancer Res 1990;50:1822-1827.
34. Riva P, Arista A, Tison V, Sturiale C, Francheshi G, Spinelli A, et al:Intralesional radioimmunotherapy of malignant gliomas. Cancer 1994;73:1076-1082.
35. Pickles T, Goodman GB, Rheaume DE, Duncan GG, Fryer CJ, Bhimji S, et al:Pion radiation for high grade astrocytoma: Results of a randomized study. Int J Radiat Oncol Biol Phys 1997;37:491-497.
36. Soloway AH, Barth RF, Gahbauer RA, Blue TE, Goodman JH:The rationale and requirements for the development of boron neutron capture therapy of brain tumors. J Neurooncol 1997;33:9-18.
37. Feinendegen LE:Strategic planning workshop on research needs for neutron capture therapy. J Neurooncol 1997;33:179-185.
38. Barth RF, Soloway AH:Boron neutron capture therapy of brain tumors - Current status and future prospects. J Neurooncol 1997;33:3-7.
39. Rajan B, Ross G, Lim CC, Ashley S, Goode D, Traish D, et al:Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy. Eur J Cancer 1994;12:1809-1815.
40. Leibel SA, Gutin PH, Wara WM, Silver PA, Larson DA, Edwards MSB, et al:Survival and quality of life after interstitial implantation of removable high activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989;17:1129-1139.
41. Shrieve DC, Alexander EI, Wen PY, Fine HA, Kooy HM, Black PM, et al:Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastomamultiforme. Neurosurgery 1995;36:275-282.
42. Shepherd SF, Laing RW, Cosgrove VP,Warrington AP, Hines F, Ashley SE, et al:Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997;37:393-398.